Clinical usefulness of tissue acquisition of pancreatic cystic lesions using an endoscopic ultrasound-guided needle for histological analysis

Abstract

Background and study aims There are rare data on the usefulness of endosonography-guided tissue acquisition (EUS-TA) in patients with pancreatic cystic lesions (PCLs). This study aimed to determine the accuracy of EUS-TA with ProCore 20G (PC20) for differentiating between mucinous neoplasia (MN) and non-MNs (n-MN) and identifying malignant PCLs, as well as its adverse events (AEs) in patients with PCLs without a classificatory diagnosis by imaging exams.

Patients and methods In this observational, retrospective, single-center study, all patients with PCL who underwent EUS-TA due to diagnostic doubts in imaging studies were consecutively recruited from June 2017 to December 2021. The outcomes were to determine the diagnostic accuracy of EUS-TA with PC20 for differentiating between MN and n-MN, identifying malignant PCLs, and the AEs.

Results Herein, 145 patients underwent EUS-TA, with 83 women (57.2%) and a mean age of 62.2 years. The mean size was 2.3 cm, with 81 patients (77.9%) having a PCL < 3.0 cm. The final diagnosis was made by EUS-TA (n = 81), surgery (n = 58), and follow-up (n = 6). The sensitivity, specificity, positive and negative predictive values, and accuracy for differentiating between MNs and n-MNs and identifying malignant PCLs were 92.6%, 98.4%, 98.7%, 91.3%, and 95.2% (kappa=0.9), and 92%, 99.2%, 95.8%, 98.3%, and 97.9% (kappa = 0.93), respectively. The AE rate was 2.7%, with no deaths in this cohort.

Conclusions EUS-TA with PC20 has high accuracy and technical success with a low AE rate for PCL diagnosis.

Keywords

Fine-needle aspiration/biopsy - Endoscopic ultrasonography - Intervention EUS - Pancreas - Tissue diagnosis

• References

• 1 Schraibman V, Goldman SM, Ardengh JC. et al. New trends in diffusion-weighted magnetic resonance imaging as a tool in differentiation of serous cystadenoma and mucinous cystic tumor: a prospective study. Pancreatology 2011; 11: 43-51
• 2 Zerboni G, Signoretti M, Crippa S. et al. Systematic review and meta-analysis: prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals. Pancreatology 2019; 19: 2-9
• 3 Marinelli V, Secchettin E, Andrianello S. et al. Psychological distress in patients under surveillance for intraductal papillary mucinous neoplasms of the pancreas: the “Sword of Damocles” effect calls for an integrated medical and psychological approach a prospective analysis. Pancreatology 2020; 20: 505-510
• 4 Tanaka M, Fernández-Del Castillo C, Kamisawa T. et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 2017; 17: 738-753
• 5 Dumonceau JM, Deprez PH, Jenssen C. et al. Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline – updated January 2017. Endoscopy 2017; 49: 695-714
• 6 Brugge WR, Lewandrowski K, Lee-Lewandrowski E. et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 2004; 126: 1330-1336
• 7 Vaiciunas S, Taglieri E, Micelli-Neto O. et al. Endoscopic ultrasound-guided fine-needle aspiration microhistology in asymptomatic and symptomatic pancreatic cystic lesions. Pancreas 2020; 49: 584-590
• 8 Facciorusso A, Kovacevic B, Yang D. et al. Predictors of adverse events after endoscopic ultrasound-guided through-the-needle biopsy of pancreatic cysts: a recursive partitioning analysis. Endoscopy 2022; 54: 1158-1168
• 9 Ardengh JC, Brunaldi VO, Brunaldi MO. et al. Is the new procore 20G double forward-bevel needle capable to obtain better histological samples by endoscopic ultrasound for diagnosing solid pancreatic lesions?. Arq Bras Cir Dig 2021; 33: e1554
• 10 Armellini E, Manfrin E, Trisolini E. et al. Histologic retrieval rate of a newly designed side-bevelled 20G needle for EUS-guided tissue acquisition of solid pancreatic lesions. U Eur Gastroenterol J 2019; 7: 96-104
• 11 van Riet PA, Larghi A, Attili F. et al. A multicenter randomized trial comparing a 25-gauge EUS fine-needle aspiration device with a 20-gauge EUS fine-needle biopsy device. Gastrointest Endosc 2019; 89: 329-339
• 12 Ardengh JC, Lopes CV, de Lima LF. et al. Cell block technique and cytological smears for the differential diagnosis of pancreatic neoplasms after endosonography-guided fine-needle aspiration. Acta Gastroenterol Latinoam 2008; 38: 246-251
• 13 Compton CC. Protocol for the examination of specimens from patients with endocrine tumors of the pancreas, including those with mixed endocrine and acinar cell differentiation: a basis for checklists. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med 2000; 124: 30-36
• 14 Khandelwal M, Lichtenstein GR, Morris JB. et al. Abdominal lymphangioma masquerading as a pancreatic cystic neoplasm. J Clin Gastroenterol 1995; 20: 142-144
• 15 Rampy BA, Waxman I, Xiao SY. et al. Serous cystadenoma of the pancreas with papillary features: a diagnostic pitfall on fine-needle aspiration biopsy. Arch Pathol Lab Med 2001; 125: 1591-1594
• 16 Basturk O, Hong SM, Wood LD. et al. A revised classification system and recommendations from the Baltimore consensus meeting for neoplastic precursor lesions in the pancreas. Am J Surg Pathol 2015; 39: 1730-1741
• 17 Ardengh JC, Lopes CV, Venco FE. et al. Diagnosis of pancreatic solid pseudopapillary neoplasms using cell-blocks and immunohistochemical evaluation of endoscopic ultrasound-guided fine needle aspiration biopsy specimens. Cytopathology 2021; 32: 50-56
• 18 Kongkam P, Al-Haddad M, Attasaranya S. et al. EUS and clinical characteristics of cystic pancreatic neuroendocrine tumors. Endoscopy 2008; 40: 602-605
• 19 Nass KJ, Zwager LW, van der Vlugt M. et al. Novel classification for adverse events in GI endoscopy: the AGREE classification. Gastrointest Endosc 2022; 95: 1078-1085
• 20 Lee BS, Nguyen AK, Tekeste TF. et al. Long-term follow-up of branch-duct intraductal papillary mucinous neoplasms with No change in first 5 years of diagnosis. Pancreatology 2021; 21: 144-154
• 21 McCarty TR, Paleti S, Rustagi T. Molecular analysis of EUS-acquired pancreatic cyst fluid for KRAS and GNAS mutations for diagnosis of intraductal papillary mucinous neoplasia and mucinous cystic lesions: a systematic review and meta-analysis. Gastrointest Endosc 2021; 93: 1019-1033.e5
• 22 Sakorafas GH, Smyrniotis V, Reid-Lombardo KM. et al. Primary pancreatic cystic neoplasms revisited. Part III. Intraductal papillary mucinous neoplasms. Surg Oncol 2011; 20: e109-e118
• 23 Giannone F, Crippa S, Aleotti F. et al. Improving diagnostic accuracy and appropriate indications for surgery in pancreatic cystic neoplasms: the role of EUS. Gastrointest Endosc 2022; 96: 648-656.e2
• 24 Roldán J, Harrison JM, Qadan M. et al. Evolving trends in pancreatic cystic tumors: a 3-decade single-center experience with 1290 resections. Ann Surg 2023; 277: 491-497
• 25 Ardengh JC, Lopes CV, de Lima-Filho ER. et al. Impact of endoscopic ultrasound-guided fine-needle aspiration on incidental pancreatic cysts. A prospective study. Scand J Gastroenterol 2014; 49: 114-120
• 26 Wang QX, Xiao J, Orange M. et al. EUS-guided FNA for diagnosis of pancreatic cystic lesions: a meta-analysis. Cell Physiol Biochem 2015; 36: 1197-1209
• 27 Thornton GD, McPhail MJ, Nayagam S et tal. Endoscopic ultrasound guided fine needle aspiration for the diagnosis of pancreatic cystic neoplasms: a meta-analysis. Pancreatology 2013; 13: 48-57
• 28 Barresi L, Tacelli M, Ligresti D. et al. Tissue acquisition in pancreatic cystic lesions. Dig Liver Dis 2019; 51: 286-292
• 29 Park WG, Wu M, Bowen R. et al. Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine. Gastrointest Endosc 2013; 78: 295-302.e2
• 30 Lopes CV. Cyst fluid glucose: an alternative to carcinoembryonic antigen for pancreatic mucinous cysts. World J Gastroenterol 2019; 25: 2271-2278
• 31 de Jong K, Poley JW, van Hooft JE. et al. Endoscopic ultrasound-guided fine-needle aspiration of pancreatic cystic lesions provides inadequate material for cytology and laboratory analysis: initial results from a prospective study. Endoscopy 2011; 43: 585-590
• 32 Estrada P, Benson M, Gopal D. et al. Cytology with rapid on-site examination (ROSE) does not improve diagnostic yield of EUS-FNA of pancreatic cystic lesions. Diagn Cytopathol 2019; 47: 1184-1189
• 33 Du C, Chai NL, Linghu EQ. et al. Incidents and adverse events of endoscopic ultrasound-guided fine-needle aspiration for pancreatic cystic lesions. World J Gastroenterol 2017; 23: 5610-5618
• 34 Phan J, Dawson D, Sedarat A. et al. Clinical utility of obtaining endoscopic ultrasound-guided fine-needle biopsies for histologic analyses of pancreatic cystic lesions. Gastroenterology 2020; 158: 475-477.e1
• 35 Luo S, Li DF, Guo L. et al. Severe acute pancreatitis caused by endoscopic ultrasonography-guided fine-needle biopsy of a pancreatic solid pseudopapillary neoplasm. Endoscopy 2021; 53: E322-E323
• 36 Facciorusso A, Buccino VR, Sacco R. Needle-based confocal laser endomicroscopy in pancreatic cysts: a meta-analysis. Eur J Gastroenterol Hepatol 2020; 32: 1084-1090
• 37 Nakai Y, Iwashita T, Park DH. et al. Diagnosis of pancreatic cysts: EUS-guided, through-the-needle confocal laser-induced endomicroscopy and cystoscopy trial: DETECT study. Gastrointest Endosc 2015; 81: 1204-1214